Generated by DeepSeek V3.2| Banner Alzheimer's Institute | |
|---|---|
| Name | Banner Alzheimer's Institute |
| Established | 2006 |
| Founder | Pierre N. Tariot |
| Headquarters | Phoenix, Arizona, United States |
| Affiliation | Banner Health |
| Focus | Alzheimer's disease research and care |
| Website | https://www.banneralz.org |
Banner Alzheimer's Institute is a pioneering research and clinical care center dedicated to the study, treatment, and prevention of Alzheimer's disease and related dementias. Founded in 2006 as part of the non-profit Banner Health system, it is headquartered in Phoenix, Arizona. The institute is internationally recognized for its innovative approach to clinical trials, particularly in the realm of prevention, and for integrating comprehensive patient care with cutting-edge scientific investigation.
The institute was established in 2006 through the vision of co-founder Pierre N. Tariot, building upon a legacy of neurological care within the Banner Health network. Its creation was driven by the urgent need to address the growing public health crisis posed by Alzheimer's disease. From its inception, the organization aimed to challenge conventional paradigms by focusing on pre-symptomatic intervention and developing novel clinical trial methodologies. A landmark early achievement was the launch of the Alzheimer's Prevention Initiative in 2009, which positioned the institute at the forefront of global prevention research efforts.
The institute's research is organized around several core scientific programs focused on understanding the pathology and progression of Alzheimer's disease. Central to its mission is the Alzheimer's Prevention Initiative, a large-scale program designed to evaluate potential treatments in individuals at high genetic risk for the disease. Other major areas of investigation include neuroimaging studies using advanced PET scan and MRI techniques to track biomarkers, genetics research to identify risk factors, and the development of more sensitive cognitive tests. Scientists at the institute collaborate closely with partners like the University of Arizona and the Translational Genomics Research Institute to accelerate discovery.
Clinical services are fully integrated with research activities, providing comprehensive care for individuals and families affected by memory disorders. The multidisciplinary care team includes neurologists, geriatric psychiatrists, neuropsychologists, and social workers who offer diagnostic evaluations, treatment planning, and ongoing management. A key component is the Memory Disorders Clinic, which provides specialized assessments and access to the latest therapeutic interventions. The institute also emphasizes family caregiver support and education, offering counseling and resources through programs like the Banner Sun Health Research Institute's community outreach.
The institute leads several landmark national and international studies that have reshaped the Alzheimer's disease research landscape. The flagship Alzheimer's Prevention Initiative includes the pioneering API Colombia trial, conducted in collaboration with the University of Antioquia in Colombia, which studies an extended family with a specific Presenilin 1 genetic mutation. Another major effort is the Generation Study, a partnership with Novartis, Amgen, and the National Institutes of Health, which tested preventive therapies. The institute also plays a central role in the DIAN-TU (Dominantly Inherited Alzheimer Network Trials Unit) and other National Institute on Aging-funded networks.
The institute is led by a team of renowned experts in Alzheimer's disease research and clinical care. Co-founder Pierre N. Tariot serves as Director, providing strategic vision for its research agenda. The scientific leadership includes experts in neurology, geriatrics, and biostatistics who oversee the various research programs and clinical trials. The organization is structured to foster collaboration between its research divisions, clinical services, and administrative operations, all functioning under the umbrella of the larger Banner Health system to leverage institutional resources and community reach.
Collaboration is a cornerstone of the institute's strategy, involving a vast network of academic, pharmaceutical, and non-profit partners. It maintains strong ties with leading research universities, including the University of Arizona College of Medicine and Arizona State University. Major pharmaceutical collaborations have been established with companies like Genentech, Eli Lilly and Company, and Roche to conduct pivotal clinical trials. The institute is also a key contributor to global consortia such as the Alzheimer's Association's research roundtables and the Global Alzheimer's Platform Foundation, working to standardize and accelerate prevention research worldwide.
Category:Medical and health organizations based in Arizona Category:Alzheimer's disease organizations Category:Medical research institutes in the United States